Actinogen Medical Limited (ACW.AX)
AUD 0.03
(-3.85%)
AUD 0.03
(-3.85%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 9.93 Million | 4.88 Million | 3.64 Million | 1.98 Million | 3.51 Million | 4.86 Million |
| Cost of Revenue | - | 405.6 Thousand | 400.66 Thousand | 386.69 Thousand | 412.93 Thousand | 353.5 Thousand |
| Gross Profit | 9.93 Million | 4.48 Million | 3.23 Million | 1.59 Million | 3.1 Million | 4.5 Million |
| Operating Expenses | 22.77 Million | 15.46 Million | 12.77 Million | 5.51 Million | 8.49 Million | 14.94 Million |
| Selling, General and Administrative Expenses | 7.23 Million | 6.56 Million | 4.55 Million | 3.11 Million | 2.96 Million | 3.22 Million |
| Research and Development Expenses | 15.53 Million | 8.89 Million | 8.21 Million | 2.4 Million | 5.53 Million | 10.89 Million |
| Other Expenses | - | 4.77 Million | 3.65 Million | 1.98 Million | 3.51 Million | 4.78 Million |
| Cost and Expenses | 22.77 Million | 15.87 Million | 13.17 Million | 5.9 Million | 8.91 Million | 14.94 Million |
| Operating Income | -12.83 Million | -15.87 Million | -13.17 Million | -5.9 Million | -8.91 Million | -9.6 Million |
| Interest Expense | 24.29 Thousand | 16.59 Thousand | 18.47 Thousand | 22.31 Thousand | 28.88 Thousand | 7987.00 |
| Income Tax Expense | -9.93 Million | -4.88 Million | -3.64 Million | -1.83 Million | -3.31 Million | 181.64 Thousand |
| Earnings before Tax | -22.97 Million | -15.64 Million | -13.13 Million | -5.75 Million | -8.64 Million | -9.88 Million |
| Net Income | -13.04 Million | -10.75 Million | -9.49 Million | -3.91 Million | -5.33 Million | -9.88 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 2.17 Billion | 1.87 Billion | 1.78 Billion | 1.46 Billion | 1.18 Billion | 1.1 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.17 Billion | 1.87 Billion | 1.78 Billion | 1.46 Billion | 1.18 Billion | 1.1 Billion |
| Gross Margin | 1.00 | 0.92 | 0.89 | 0.81 | 0.88 | 0.93 |
| EBIT Margin | -1.30 | -3.16 | -3.51 | -2.78 | -2.42 | -1.90 |
| Profit Margin | -1.31 | -2.20 | -2.61 | -1.97 | -1.52 | -2.03 |
| EBITDA | -12.92 Million | -15.21 Million | -12.71 Million | -5.34 Million | -8.2 Million | -9.25 Million |
| Earnings Before Tax Margin | -1.29 | -3.25 | -3.62 | -2.98 | -2.53 | -1.98 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.02 Million | - | 909.03 Thousand | 4.88 Million | 3.88 Million | 1 Million |
| Cost of Revenue | 204.86 Thousand | 416.83 Thousand | 211.96 Thousand | 405.6 Thousand | 204.55 Thousand | 201.05 Thousand |
| Gross Profit | 8.81 Million | -416.83 Thousand | 697.06 Thousand | 4.48 Million | 3.67 Million | 803.04 Thousand |
| Operating Expenses | 10.42 Million | 22.77 Million | 12.35 Million | 15.46 Million | 7.18 Million | 8.28 Million |
| Selling, General and Administrative Expenses | 3.83 Million | - | 3.39 Million | - | 3.66 Million | 2.89 Million |
| Research and Development Expenses | 6.58 Million | - | 8.95 Million | - | 3.51 Million | 5.38 Million |
| Other Expenses | - | - | - | 4.77 Million | - | - |
| Cost and Expenses | 10.42 Million | 23.18 Million | 12.56 Million | 15.87 Million | 7.38 Million | 8.48 Million |
| Operating Income | -1.39 Million | -23.18 Million | -12.56 Million | -15.87 Million | -7.38 Million | -8.48 Million |
| Interest Expense | 13.17 Thousand | 24.29 Thousand | 11.11 Thousand | 16.59 Thousand | 6538.00 | 10.06 Thousand |
| Income Tax Expense | -9.02 Million | -9.93 Million | -909.03 Thousand | -4.88 Million | -3.88 Million | -1 Million |
| Earnings before Tax | -1.48 Million | -22.97 Million | -12.46 Million | -15.64 Million | -7.19 Million | -8.44 Million |
| Net Income | -1.48 Million | -13.04 Million | -11.55 Million | -10.75 Million | -3.31 Million | -7.43 Million |
| Earnings Per Share Basic | -0.00 | - | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 2.28 Billion | 2.17 Billion | 2.33 Billion | 1.87 Billion | 1.91 Billion | 1.9 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.28 Billion | 2.17 Billion | 2.33 Billion | 1.87 Billion | 1.91 Billion | 1.9 Billion |
| Gross Margin | 0.98 | - | 0.77 | 0.92 | 0.95 | 0.80 |
| EBIT Margin | -0.16 | - | -13.59 | - | -1.85 | -8.25 |
| Profit Margin | -0.16 | - | -12.71 | -2.20 | -0.85 | -7.41 |
| EBITDA | -1.43 Million | - | -12.35 Million | - | -7.18 Million | -8.28 Million |
| Earnings Before Tax Margin | -0.15 | - | -13.82 | -3.25 | -1.90 | -8.45 |
7919
IMFA
LZAGF
KYKOF
BRITANNIA
YONG